WINTON GROUP Ltd Buys 28,008 Shares of Tilray Inc (NASDAQ:TLRY)

WINTON GROUP Ltd raised its stake in shares of Tilray Inc (NASDAQ:TLRY) by 46.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 88,401 shares of the company’s stock after acquiring an additional 28,008 shares during the quarter. WINTON GROUP Ltd’s holdings in Tilray were worth $118,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in TLRY. Verdence Capital Advisors LLC acquired a new stake in shares of Tilray during the 4th quarter worth about $29,000. Dudley Capital Management LLC bought a new stake in Tilray during the fourth quarter worth about $29,000. Ameritas Advisory Services LLC acquired a new stake in shares of Tilray during the fourth quarter worth approximately $32,000. Newman Dignan & Sheerar Inc. raised its stake in shares of Tilray by 61.9% in the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company’s stock valued at $35,000 after acquiring an additional 10,000 shares during the last quarter. Finally, Brooklyn FI LLC acquired a new position in shares of Tilray in the 4th quarter worth approximately $36,000. Institutional investors and hedge funds own 9.35% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group raised their price target on Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a report on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $2.70.

Tilray Trading Down 0.8 %

Shares of NASDAQ TLRY opened at $0.66 on Tuesday. Tilray Inc has a 1-year low of $0.58 and a 1-year high of $2.97. The company has a 50-day moving average of $0.84 and a two-hundred day moving average of $1.25. The company has a market cap of $616.51 million, a PE ratio of -2.19 and a beta of 2.13. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The company had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The business’s revenue was up 8.7% on a year-over-year basis. As a group, equities analysts expect that Tilray Inc will post -0.2 earnings per share for the current fiscal year.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.